Yacoub Habib

CEO at Ophidion, Inc.

Presenter

Yacoub Habib, Ph.D., MBA, is the chief executive officer and Chairman of the Board for Ophidion, Inc. He has more than 28 years of senior executive experience in the pharmaceutical industry. Dr. Habib most recently served as senior vice president, business development and corporate planning at Trevena, where he was since July 2015. Previously, from 2009 to June 2015, he served as vice president of business development at Ikaria, Inc. and led the business development strategy for the company until its acquisition by Mallinckrodt. From 2007 to 2009, he served as executive director of new business development for Pfizer Inc. Before joining Pfizer, Dr. Habib was executive director of global business development for Organon Pharmaceuticals, a division of Akzo Nobel, where he was responsible for the identification, evaluation, and negotiation of in-licensing, out-licensing, and divestiture opportunities in neuroscience, fertility, and women health. He started his career at Bristol Myers Squibb where he spent eleven years in various research, corporate, and business development roles, including director of business development. Dr. Habib holds a Ph.D. in pharmaceutical sciences from the University of Maryland and an MBA with a major in finance and marketing from New York University, Stern School of Business.